PDLIM7 and non-Hodgkin lymphoma: While we observed a comparably high LMP-1 peptide diversity in patients with symptomatic and asymptomatic EBV infections (Figures 1A, B), the LMP-1 GGDPHLPTL peptide was the only variant we detected in EBV+HL and EBV+nHL patients (Figures 1C, D, S1B-C).